IpiNovyx Bio
West Nyack, US · Founded 2021 · Delaware corporation · 1 known investors
IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Its technology originated from research at Weill Cornell Medicine and the Hospital for Special Surgery, and it is advancing these preclinical programs toward clinical applications.
BiotechHealthtechMedical Devices
Founders & leadership
MA
Marc AppelNamed on SEC filing
LG
Lutz GiebelNamed on SEC filing
JG
James GrahamNamed on SEC filing
GL
Gang LinScientific Founder
CN
Carl NathanScientific Founder
FB
Franck BarratScientific Founder
Investors · 1
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2021
▶$7MraisedOct 2021 · 12 investors · Other Health CareRule 506(b)
▶$7MraisedOct 2021 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc AppelExecutive Officer, Director
- Lutz GiebelDirector
- James GrahamDirector
- Offering amount
- $10M
- Amount sold
- $7M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does IpiNovyx Bio do?
- IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Its technology originated from research at Weill Cornell Medicine and the Hospital for Special Surgery, and it is advancing these preclinical programs toward clinical applications.
- Who are IpiNovyx Bio's investors?
- IpiNovyx Bio's investors include Pathway Bioventures.
- How much funding has IpiNovyx Bio raised?
- IpiNovyx Bio has disclosed $7M raised across 1 round.
- Where is IpiNovyx Bio headquartered?
- IpiNovyx Bio is headquartered in West Nyack, US.